Author:
Sakthianandeswaren Anuratha,Sabljak Polly,J. Elliott Meg,Palmieri Michelle,M. Sieber Oliver
Reference105 articles.
1. Surveillance, Epidemiology, and End Results Program SEER Facts and Figures. Colorectal Cancer. National Cancer Institute. 2018. [cited Jul 20, 2018]. Available from: https://seer.cancer.gov/statfacts/html/colorect.html
2. Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Annals of Oncology. 2016;27(8):1386-1422
3. Zhao B, Wang L, Qiu H, Zhang M, Sun L, Peng P, et al. Mechanisms of resistance to anti-EGFR therapy in colorectal cancer. Oncotarget. 2017;8(3):3980-4000
4. Brand TM, Iida M, Wheeler DL. Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab. Cancer Biology & Therapy. 2011;11(9):777-792
5. Tebbutt N, Pedersen MW, Johns TG. Targeting the ERBB family in cancer: couples therapy. Nature Reviews. Cancer. 2013;13(9):663-673
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献